The EP300-ZNF384 fusion gene is a common genomic lesion in patients with acute B lymphoblastic leukemia (B-ALL) and B/M mixed phenotype acute leukemia (MPAL) [1, 2]. This evidence concerns the gene EP300 and precursor B-cell acute lymphoblastic leukemia.